Exagen Diagnostics Inc-医療機器分野:企業M&A・提携分析

◆英語タイトル:Exagen Diagnostics Inc - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8012885
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月27日
◆ページ数:32
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Exagen Diagnostics Inc (Exagen) is a medical device company that offers diagnostic tools. The company provides clinical tools for diagnosis, monitoring and prognosis of autoimmune connective tissue disease. Its products are used for therapeutic drug monitoring of hydroxychloroquine in whole blood and methotrexate polyglutamates, risk assessment testing, anti-TNF monitoring to individualize therapy and optimize dosing, and others. Exagen offers avise ctd, avise sle prognostic, avise infliximab and avise adalimumab, avise hcq, and avise mtx. The company serves physicians and patients. It operates in Vista and Albuquerque, the US. Exagen is headquartered in Vista, California, the US.

Exagen Diagnostics Inc – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Exagen Diagnostics Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Exagen Diagnostics Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Exagen Diagnostics Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Exagen Diagnostics Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
Exagen Diagnostics Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Exagen Diagnostics Inc, Medical Equipment, Deal Details 10
Venture Financing 10
Exagen Diagnostics Raises USD1.3 Million in Venture Financing 10
Exagen Diagnostics Raises USD1.5 Million in Venture Financing 11
Exagen Diagnostics Raises USD1 Million in Venture Financing 12
Exagen Diagnostics Raises USD1 Million in Venture Financing 13
Exagen Diagnostics Raises USD1 Million in Venture Financing 14
Exagen Diagnostics Raises USD1 Million in Venture Financing 15
Exagen Diagnostics Raises USD1 Million in Venture Financing 16
Exagen Diagnostics Raises USD1 Million in venture financing 17
Exagen Diagnostics Raises USD2 Million in Venture Financing 18
Exagen Diagnostics Raises USD16.81 Million in Venture Financing 19
Exagen Diagnostics Raises USD3 Million in Venture Financing 20
Exagen Diagnostics Raises USD2 Million in Venture Financing 21
Exagen Diagnostics Raises USD4 Million in Venture Financing 22
Exagen Diagnostics Raises US$5 Million In Venture Financing 23
Exagen Diagnostics Raises US$0.12 Million In Venture Financing 24
Exagen Raises US$5.3 Million In Venture Financing 25
Exagen Diagnostics Secures US$12 Million In Series D Venture Financing 26
Exagen Diagnostics Secures Additional US$3.4 Million In Financing Round 27
Exagen Diagnostics Inc – Key Competitors 28
Exagen Diagnostics Inc – Key Employees 29
Exagen Diagnostics Inc – Locations And Subsidiaries 30
Head Office 30
Other Locations & Subsidiaries 30
Recent Developments 31
Product News 31
Oct 31, 2017: Exagen Diagnostics Featured in Five Scientific Posters at 2017 ACR/ARHP Annual Meeting in San Diego 31
Appendix 32
Methodology 32
About GlobalData 32
Contact Us 32
Disclaimer 32

List of Tables
Exagen Diagnostics Inc, Medical Equipment, Key Facts 2
Exagen Diagnostics Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Exagen Diagnostics Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Exagen Diagnostics Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Exagen Diagnostics Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Exagen Diagnostics Inc, Deals By Market, 2011 to YTD 2017 8
Exagen Diagnostics Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Exagen Diagnostics Raises USD1.3 Million in Venture Financing 10
Exagen Diagnostics Raises USD1.5 Million in Venture Financing 11
Exagen Diagnostics Raises USD1 Million in Venture Financing 12
Exagen Diagnostics Raises USD1 Million in Venture Financing 13
Exagen Diagnostics Raises USD1 Million in Venture Financing 14
Exagen Diagnostics Raises USD1 Million in Venture Financing 15
Exagen Diagnostics Raises USD1 Million in Venture Financing 16
Exagen Diagnostics Raises USD1 Million in venture financing 17
Exagen Diagnostics Raises USD2 Million in Venture Financing 18
Exagen Diagnostics Raises USD16.81 Million in Venture Financing 19
Exagen Diagnostics Raises USD3 Million in Venture Financing 20
Exagen Diagnostics Raises USD2 Million in Venture Financing 21
Exagen Diagnostics Raises USD4 Million in Venture Financing 22
Exagen Diagnostics Raises US$5 Million In Venture Financing 23
Exagen Diagnostics Raises US$0.12 Million In Venture Financing 24
Exagen Raises US$5.3 Million In Venture Financing 25
Exagen Diagnostics Secures US$12 Million In Series D Venture Financing 26
Exagen Diagnostics Secures Additional US$3.4 Million In Financing Round 27
Exagen Diagnostics Inc, Key Competitors 28
Exagen Diagnostics Inc, Key Employees 29
Exagen Diagnostics Inc, Other Locations 30

★海外企業調査レポート[Exagen Diagnostics Inc-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Asarina Pharma AB-製薬・医療分野:企業M&A・提携分析
    Summary Asarina Pharma AB (Asarina Pharma), formerly Umecrine Mood AB, a subsidiary of Umecrine AB is a drug development company that concentrates on the discovery, development and commercialization of novel treatments for women suffering from premenstrual dysphoric disorder and other menstrual cycl …
  • Cynvenio Biosystems Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Cynvenio Biosystems Inc (Cynvenio) is a cancer diagnostic company that focuses on transforming cancer treatment and management through the molecular analysis of cancer biomarkers in blood. The company offers products such as lab automation systems, isolation products and proprietary informat …
  • Jiangsu Hengrui Medicine Co Ltd (600276):製薬・医療:M&Aディール及び事業提携情報
    Summary Jiangsu Hengrui Medicine Co Ltd (Jiangsu Hengrui) is a biopharmaceutical company that focuses on the research, development, manufacture and distribution of novel pharmaceutical products. Its product portfolio includes antineoplastic products, anti-tumor drugs, surgical drugs and contrast age …
  • Adamis Pharmaceuticals Corp (ADMP):医療機器:M&Aディール及び事業提携情報
    Summary Adamis Pharmaceuticals Corp (Adamis), formerly Cellegy Pharmaceuticals Inc, is a biopharmaceutical company that develops therapies in areas of respiratory disease and allergy. The company offers pipeline product, epinephrine pre-filled syringe is developed for anaphylactic reactions such as …
  • Seiko Epson Corporation:企業の戦略・SWOT・財務分析
    Seiko Epson Corporation - Strategy, SWOT and Corporate Finance Report Summary Seiko Epson Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • TOP Ships Inc (TOPS):石油・ガス:M&Aディール及び事業提携情報
    Summary TOP Ships Inc (Top Ships), formerly known as Top Tankers Inc., is a provider of international seaborne transportation services. It owns and operates eco medium range (MR) tanker vessels focusing on the transportation of petroleum products, crude oil and bulk liquid chemicals. The company ser …
  • WABCO Holdings Inc.:企業の戦略・SWOT・財務情報
    WABCO Holdings Inc. - Strategy, SWOT and Corporate Finance Report Summary WABCO Holdings Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • EnCana Corp (ECA):石油・ガス:M&Aディール及び事業提携情報
    Summary EnCana Corp (EnCana) is an oil and gas producer. The company explores, develops, produces and markets natural gas, oil and natural gas liquids (NGLs). Its major resource plays include Montney, Duvernay, Wheatland Oil play, Deep Panuke, Horn River and other emerging plays in Canada. In the US …
  • The Credit Mutuel-Cic Group:企業の戦略・SWOT・財務分析
    The Credit Mutuel-Cic Group - Strategy, SWOT and Corporate Finance Report Summary The Credit Mutuel-Cic Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Empire Resorts Inc:戦略・SWOT・企業財務分析
    Empire Resorts Inc - Strategy, SWOT and Corporate Finance Report Summary Empire Resorts Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Manali Petrochemicals Ltd (MANALIPETC):企業の財務・戦略的SWOT分析
    Summary Manali Petrochemicals Ltd (MPL), a subsidiary of Southern Petrochemical Industries Corp Ltd, is a chemical company that develops and markets petrochemical products. The company offers products such as propylene oxide, propylene glycol, flexible and molded polyols, rigid polyols and elastomer …
  • AeroControlex Group Inc.:企業の戦略・SWOT・財務情報
    AeroControlex Group Inc. - Strategy, SWOT and Corporate Finance Report Summary AeroControlex Group Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • The Scotts Miracle-Gro Company (SMG):企業の財務・戦略的SWOT分析
    The Scotts Miracle-Gro Company (SMG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Pinnacle Biologics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Pinnacle Biologics Inc (Pinnacle Biologics), a subsidiary of Concordia International Corp is a drug development company that develops and markets photodynamic therapy products. The company offers products such as OPTIGUIDE PI, ETHYOL PI, PHOTOFRIN PI, and DIOMED products, among others. Its O …
  • Showa Denko Materials Co Ltd:企業の戦略的SWOT分析
    Showa Denko Materials Co Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …
  • Bharat Petroleum Corporation Limited:企業の戦略・SWOT・財務情報
    Bharat Petroleum Corporation Limited - Strategy, SWOT and Corporate Finance Report Summary Bharat Petroleum Corporation Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …
  • Herman Miller, Inc.:企業の戦略・SWOT・財務分析
    Herman Miller, Inc. - Strategy, SWOT and Corporate Finance Report Summary Herman Miller, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Novant Health Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Novant Health Inc (Novant Health) is a not-for-profit, integrated healthcare service provider. The organization provides services related to assisted living, blood services, breast health, children’s services, laboratory services, emergency, laboratory services, cancer, urgent care, hospice …
  • Gazprom (GAZP):電力:M&Aディール及び事業提携情報
    Summary Gazprom is an integrated global oil and gas company. It carries out the exploration, production, transportation, storage, processing and marketing of natural gas, gas condensate and crude oil. The company also sells gas as a vehicle fuel and participates in the generation and marketing of he …
  • Change Healthcare, LLC:企業の戦略的SWOT分析
    Change Healthcare, LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆